<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OTO</journal-id>
<journal-id journal-id-type="hwp">spoto</journal-id>
<journal-title>Otolaryngology–Head and Neck Surgery</journal-title>
<issn pub-type="ppub">0194-5998</issn>
<issn pub-type="epub">1097-6817</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0194599812451010</article-id>
<article-id pub-id-type="publisher-id">10.1177_0194599812451010</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Sinonasal Disorders</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Improving the Detection of Fungi in Eosinophilic Mucin</article-title>
<subtitle>Seeing What We Could Not See Before</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Guo</surname><given-names>Canting</given-names></name>
<xref ref-type="aff" rid="aff1-0194599812451010">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ghadersohi</surname><given-names>Saied</given-names></name>
<xref ref-type="aff" rid="aff1-0194599812451010">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kephart</surname><given-names>Gail M.</given-names></name>
<xref ref-type="aff" rid="aff2-0194599812451010">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Laine</surname><given-names>Roger A.</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff3-0194599812451010">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Sherris</surname><given-names>David A.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff4-0194599812451010">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kita</surname><given-names>Hirohita</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0194599812451010">2</xref>
<xref ref-type="aff" rid="aff5-0194599812451010">5</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ponikau</surname><given-names>Jens U.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff4-0194599812451010">4</xref>
</contrib>
</contrib-group>
<aff id="aff1-0194599812451010"><label>1</label>University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, USA</aff>
<aff id="aff2-0194599812451010"><label>2</label>Allergic Diseases Research Laboratory, Mayo Clinic, Rochester, Minnesota, USA</aff>
<aff id="aff3-0194599812451010"><label>3</label>Department of Biological Sciences and Chemistry, Louisiana State University, Baton Rouge, Louisiana, USA</aff>
<aff id="aff4-0194599812451010"><label>4</label>Department of Otolaryngology, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, USA</aff>
<aff id="aff5-0194599812451010"><label>5</label>Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA</aff>
<author-notes>
<corresp id="corresp1-0194599812451010">Canting Guo, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, Gromo Sinus Center, 1237 Delaware Ave, Buffalo, NY 14209, USA Email: <email>cantingg@buffalo.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>11</month>
<year>2012</year>
</pub-date>
<volume>147</volume>
<issue>5</issue>
<fpage>943</fpage>
<lpage>949</lpage>
<history>
<date date-type="received">
<day>2</day>
<month>3</month>
<year>2012</year>
</date>
<date date-type="rev-recd">
<day>24</day>
<month>4</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>5</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation</copyright-holder>
</permissions>
<abstract>
<sec id="section1-0194599812451010">
<title>Objective</title>
<p>To investigate the improvement in histologic detection of fungi with Gomori methenamine silver (GMS) stain by trypsin predigestion in the mucus of patients with chronic rhinosinusitis (CRS).</p>
</sec>
<sec id="section2-0194599812451010">
<title>Study Design</title>
<p>Prospective, single group, descriptive analysis.</p>
</sec>
<sec id="section3-0194599812451010">
<title>Setting</title>
<p>Multi-institutional.</p>
</sec>
<sec id="section4-0194599812451010">
<title>Subjects and Methods</title>
<p>Thirty-four sinus specimens from 12 surgical patients with CRS were stained with hematoxylin and eosin, GMS stain, GMS with trypsin digestion, immunofluorescence stains for chitinase, and anti-<italic>Alternaria</italic>. All patients received skin testing, total IgE serology, and radioallergosorbent tests (RAST) for 23 fungal-specific IgE antibodies.</p>
</sec>
<sec id="section5-0194599812451010">
<title>Results</title>
<p>The conventional GMS stain detected fungi in only 9 of 34 (27%) specimens. Predigesting the specimen with trypsin dramatically improved the visualization of fungi (31/34, 91%). The chitinase immunofluorescence visualized fungi in 32 of 34 (94%), and anti-<italic>Alternaria</italic> visualized 33 of 34 specimens (97%). Only 8 of 12 (75%) patients had detectable allergies.</p>
</sec>
<sec id="section6-0194599812451010">
<title>Conclusions</title>
<p>This report describes a simple modification of the conventional GMS stain that can significantly improve the visualization of fungi on histology and explains the lack of detection in previous studies. These novel, more sensitive histologic methods reveal the presence of fungi within the eosinophilic mucin in allergic and also nonallergic CRS patients, further questioning a crucial role of an IgE-mediated pathophysiology.</p>
</sec>
</abstract>
<kwd-group>
<kwd>eosinophil</kwd>
<kwd>fungi</kwd>
<kwd>rhinosinusitis</kwd>
<kwd>sinusitis</kwd>
<kwd>CRS</kwd>
<kwd>Gomori methenamine silver</kwd>
<kwd>GMS</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Chronic rhinosinusitis (CRS) is an inflammatory disease of the nasal airways and paranasal sinuses. It accounts for more than 90% of all rhinosinusitis cases and has a prevalence of 14% in the adult population in the United States.<sup><xref ref-type="bibr" rid="bibr1-0194599812451010">1</xref></sup> The pathology is often described as an inflammatory infiltrate of predominantly eosinophils with erosion of the respiratory epithelium, accumulation of mucus in the sinuses and nasal airways, and swelling of the underlying mucosa.<sup><xref ref-type="bibr" rid="bibr2-0194599812451010">2</xref><xref ref-type="bibr" rid="bibr3-0194599812451010"/>-<xref ref-type="bibr" rid="bibr4-0194599812451010">4</xref></sup></p>
<p>Millar et al<sup><xref ref-type="bibr" rid="bibr5-0194599812451010">5</xref></sup> and Katzenstein et al<sup><xref ref-type="bibr" rid="bibr6-0194599812451010">6</xref></sup> were the first to link subgroups of CRS to the presence of fungi on histopathology. Because the mucus contained aggregations of necrotic eosinophils (which they associated with allergy), Charcot-Leyden crystals, and fungal hyphae that resembled <italic>Aspergillus</italic>, they termed the disease <italic>allergic Aspergillus sinusitis</italic>.<sup><xref ref-type="bibr" rid="bibr6-0194599812451010">6</xref></sup> Katzenstein et al<sup><xref ref-type="bibr" rid="bibr6-0194599812451010">6</xref></sup> performed a retrospective histologic review of 119 surgical cases and found fungi in 7 of 119 sinus specimens using the Gomori methenamine silver (GMS) stain. In 1989, Robson et al<sup><xref ref-type="bibr" rid="bibr7-0194599812451010">7</xref></sup> reported a case with similar histopathological findings, but culture results revealed the presence of <italic>Bipolaris hawaiiensis</italic>, so they changed the terminology to <italic>allergic fungal sinusitis</italic> (AFS). Allphin et al<sup><xref ref-type="bibr" rid="bibr8-0194599812451010">8</xref></sup> used this terminology when they documented 14 patients with AFS and identical histopathology in 1991; only 3 of 14 patients were fungal positive on GMS stain.</p><p>In 1994, Cody et al<sup><xref ref-type="bibr" rid="bibr9-0194599812451010">9</xref></sup> suggested diagnosing AFS in 1 of 2 ways: positive fungal culture from mucus or direct observation of fungi in mucin by GMS stain. Mucus specimens from patients that resembled AFS but lacked fungal hyphae were called “AFS-like syndrome.” Six years later, Ferguson<sup><xref ref-type="bibr" rid="bibr10-0194599812451010">10</xref></sup> renamed the “AFS-like syndrome” to <italic>eosinophilic mucin rhinosinusitis</italic> (EMRS), stating that “EMRS is histologically similar to AFS except for the absence of fungus.”</p>
<p>Other studies subsequently examined histological specimens in a prospective fashion and used rigorous intraoperative collection methods that maximized mucin preservation, detecting fungal hyphae or fungal elements with a much higher yield (75%-81%) in unselected surgical CRS patients.<sup><xref ref-type="bibr" rid="bibr2-0194599812451010">2</xref>,<xref ref-type="bibr" rid="bibr11-0194599812451010">11</xref></sup></p>
<p>Other methodologies such as culture, polymerase chain reaction (PCR), and fungal antigen detection have yielded positive fungal results close to or approaching 100%,<sup><xref ref-type="bibr" rid="bibr12-0194599812451010">12</xref>,<xref ref-type="bibr" rid="bibr13-0194599812451010">13</xref></sup> suggesting a sensitivity issue with the detection of fungi using GMS staining.</p>
<p>The use of a novel fluorescein-labeled chitinase stain confirmed this suspicion because it further increased the fungal detection rate as compared with that obtained using GMS stain. On serial sections, chitinase was clearly highlighting fungal organisms that were invisible in the corresponding GMS stain.<sup><xref ref-type="bibr" rid="bibr14-0194599812451010">14</xref></sup> This suggested for the first time that the GMS method used thus far in all the previous studies lacked sensitivity to detect fungal organisms in eosinophilic mucin.<sup><xref ref-type="bibr" rid="bibr15-0194599812451010">15</xref></sup></p>
<p>The GMS stain has been the gold standard in the histological identification of fungi in mucus; however, there has been variable success in identifying fungi using GMS. The percentage of CRS patients who have positive fungal GMS staining ranged from 11% to 81%.<sup><xref ref-type="bibr" rid="bibr6-0194599812451010">6</xref>,<xref ref-type="bibr" rid="bibr9-0194599812451010">9</xref>,<xref ref-type="bibr" rid="bibr16-0194599812451010">16</xref><xref ref-type="bibr" rid="bibr17-0194599812451010"/><xref ref-type="bibr" rid="bibr18-0194599812451010"/>-<xref ref-type="bibr" rid="bibr19-0194599812451010">19</xref></sup> The inadequate collection of mucus specimens and the limited sensitivity of the GMS staining method could explain the discrepancies in the fungal detection rates between the previous studies.</p>
<p>Although immunofluorescence staining appears to be sensitive and specific for fungi, it is too complex to use in a routine clinical setting. Here, we introduce a modification to the GMS staining that uses a predigestion of the surgical specimen with trypsin to increase the detection rate of fungi in mucus specimens from CRS patients. In this study, we were seeking to compare this new method with the conventional GMS stain as well as its sensitivity to highly sensitive and specific immunofluorescence stains using chitinase and anti-<italic>Alternaria</italic>.</p>
<sec id="section7-0194599812451010" sec-type="methods">
<title>Methods</title>
<p>The State University of New York at Buffalo Health Sciences Institutional Review Board and the Mayo Clinic Institutional Review Board approved this study. We conducted a histologic analysis of 34 sinus specimens from 12 surgical patients with CRS. All patients had symptoms of CRS, including nasal congestion, post–nasal drip, sinus headache, or pressure, for more than 3 months and had undergone endoscopic sinus surgery. In addition, patients had preoperative computed tomography (CT) findings of inflammatory mucosal thickening in 2 or more sinuses.</p>
<p>Although the presence of even a small amount of eosinophilic mucin can be found in the vast majority of surgical CRS specimens, the patients for this study were preselected to have a large amount of eosinophilic mucin present during surgery to increase the size of the specimen and thus the chance to detect the fungi on histopathology. Patients who were on systemic steroids were excluded from the study. Intraoperatively, inflamed sinus tissue and mucus were removed in a fashion to ensure preservation of the attachment of the mucus to the tissue.<sup><xref ref-type="bibr" rid="bibr11-0194599812451010">11</xref></sup> Specimens were then oriented and embedded in paraffin so that the sections would display the mucus and the tissue together.</p>
<p>The paraffin blocks were cut into serial sections of 5 µm, baked onto positively charged slides, and stained with hematoxylin and eosin (H&amp;E), GMS, or immunofluorescence stains for chitinase<sup><xref ref-type="bibr" rid="bibr15-0194599812451010">15</xref></sup> and anti-<italic>Alternaria</italic>. The chitinase- and anti-<italic>Alternaria</italic>-stained sections were trypsin digested and counterstained with GMS. Trypsin-digested GMS-stained sections were treated with 0.1% porcine trypsin (Cat. No. T7168; Sigma-Aldrich, St Louis, Missouri) for half an hour at 37°C, washed, and subsequently stained with GMS.</p>
<p>The specimens were then mounted with 1 drop of Vectashield (Vector Labs, Burlingame, California) mounting medium, and a coverslip was applied. All stained specimens were stored in darkness at 4°C. Each slide was then examined with a Zeiss microscope equipped with Zeiss IV FL vertical illumination for epifluorescence and a fluorescein filter system (Carl Zeiss, Inc, Oberkochen, Germany). All specimens were initially viewed and photographed within 1 week to avoid fading.</p>
<p>Two examiners assessed each section for the presence of fungi. A specimen was considered to be positive for fungi if any of the stains visualized at least 1 fungal hyphae either circular in transverse section or tubular in longitudinal section and fulfilled all of the following 3 criteria: (1) the element demonstrated distinct, crisp staining; (2) it had characteristic fungal morphology; and (3) it traveled through the whole thickness of the specimen, indicative of a tubular structure. Then the same area was used to compare the different staining methods and determine their sensitivity and specificity to visualize the fungi present.</p>
<sec id="section8-0194599812451010">
<title>Allergy Testing</title>
<p>All patients received skin-prick tests for a panel of 16 common aeroallergens and 18 specific fungal antigens. In addition, total IgE levels were determined and radioallergosorbent tests (RAST) were performed for 23 fungal-specific IgE antibodies to maximize the chance of detecting a fungus-specific, IgE-mediated allergy.</p>
</sec>
</sec>
<sec id="section9-0194599812451010" sec-type="results">
<title>Results</title>
<p>Overall, fungi were demonstrated in all specimens. The regular GMS stain had the poorest sensitivity to visualize fungi, as only 9 of 34 specimens (27%) were positive for fungi. In contrast, the trypsin-digested GMS visualized fungi in 31 of 34 specimens (91%). The chitinase immunofluorescence visualized fungi in 32 of 34 specimens (94%), and anti-<italic>Alternaria</italic> visualized 33 of 34 specimens (97%) (<xref ref-type="table" rid="table1-0194599812451010"><bold>Table 1</bold></xref>). <xref ref-type="fig" rid="fig1-0194599812451010"><bold>Figures 1</bold></xref>, <xref ref-type="fig" rid="fig2-0194599812451010"><bold>2</bold></xref>, and <xref ref-type="fig" rid="fig3-0194599812451010"><bold>3</bold></xref> show representative specimens stained with trypsin-predigested GMS compared with the other study stains. Neither the anti-<italic>Alternaria</italic> nor the trypsin-digested GMS visualized intact fungal hyphae in 1 specimen (which was our criterion for fungal positivity). However, both stains clearly labeled fungal debris. In this case, the regular GMS stain was negative, but the chitinase stain labeled the fungal hyphae.</p>
<table-wrap id="table1-0194599812451010" position="float">
<label>Table 1.</label>
<caption><p>Fungal Detection with Different Stains</p></caption>
<graphic alternate-form-of="table1-0194599812451010" xlink:href="10.1177_0194599812451010-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">GMS</th>
<th align="center">Digested GMS</th>
<th align="center"><italic>Alternaria</italic></th>
<th align="center">Chitinase</th>
</tr>
</thead>
<tbody>
<tr>
<td>Fungus-positive specimens/total, No. (%)</td>
<td>9/34 (27)</td>
<td>31/34 (91)</td>
<td>33/34 (97)</td>
<td>32/34 (94)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0194599812451010">
<p>Abbreviation: GMS, Gomori methenamine silver.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="fig1-0194599812451010" position="float">
<label>Figure 1.</label>
<caption><p>(A) Regular Gomori methenamine silver (GMS) stain of eosinophilic mucin from an allergic chronic rhinosinusitis (CRS) patient (IgE positive to molds) showing no fungal hyphae. (B) GMS stain (5-µm serial section of A) predigested with trypsin. Numerous fungal hyphae not visible in A become apparent (white arrows). (C) Fungus-specific chitinase immunofluorescence of same section shown in B, demonstrating the improved ability of trypsin-digested GMS to label longitudinal and transverse fungi in eosinophilic mucin. (D) Hematoxylin and eosin (H&amp;E) serial section of C with fungal hyphae poorly visible. (630× original magnification)</p></caption>
<graphic xlink:href="10.1177_0194599812451010-fig1.tif"/>
</fig>
<fig id="fig2-0194599812451010" position="float">
<label>Figure 2.</label>
<caption><p>Eosinophilic mucin from a nonallergic patient illustrating similar findings as <xref ref-type="fig" rid="fig1-0194599812451010"><bold>Figure 1</bold></xref>. (A) Regular Gomori methenamine silver (GMS) stain without any visible fungal hyphae. (B) Trypsin-predigested GMS stain (5-µm serial section of A). Fungal hyphae that were not apparent in A become visible (black arrows). (C) Fungus-specific chitinase immunofluorescence (5-µm serial section of B) confirming the improved ability of trypsin-digested GMS to label fungi in eosinophilic mucin (white arrows). (D) Fungus-specific <italic>Alternaria</italic> antibody immunofluorescence of the same section shown in B. It confirms the sensitivity and specificity of trypsin-digested GMS in B. In contrast to chitinase immunofluorescence, which only labels the intact fungal cell wall, anti-<italic>Alternaria</italic> highlights fungal debris and secretions (orange arrows) not visualized with other stains. (400× original magnification)</p></caption>
<graphic xlink:href="10.1177_0194599812451010-fig2.tif"/>
</fig>
<fig id="fig3-0194599812451010" position="float">
<label>Figure 3.</label>
<caption><p>(A) Eosinophilic mucin from an allergic patient stained with trypsin-digested Gomori methenamine silver (GMS). The black arrows indicate segments of fungal hyphae fully labeled with GMS but have segments that are not labeled by GMS (blue arrows). Certain fungal hyphae do not highlight with GMS at all (yellow arrows). (B) Fungus-specific anti-<italic>Alternaria</italic> staining of the same section shown in A. The blue arrow marks the location of fungal hyphae not labeled with GMS. However, anti-<italic>Alternaria</italic> also fails to label the fungal hyphae that were indicated with yellow arrows in A. (C) Fungus-specific chitinase (serial section of A) showing segments of fungal hyphae not fully labeling with chitinase (blue arrows). B and C demonstrate that even highly specific immunofluorescence stains fail to label all the fungal elements present in a sample. (400× original magnification)</p></caption>
<graphic xlink:href="10.1177_0194599812451010-fig3.tif"/>
</fig>
<p>Allergy testing results and demographic information are summarized in <xref ref-type="table" rid="table2-0194599812451010"><bold>Table 2</bold></xref>. In short, although 8 of 12 patients were positive on a skin-prick test to a panel of 16 common aeroallergens, and 6 of the 12 were positive to fungal-specific allergens, 4 of 12 patients had no detectable allergies on both skin and RAST testing.</p>
<table-wrap id="table2-0194599812451010" position="float">
<label>Table 2.</label>
<caption><p>Demographics and Allergy Test</p></caption>
<graphic alternate-form-of="table2-0194599812451010" xlink:href="10.1177_0194599812451010-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Patients (n = 12)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Average age, y (range)</td>
<td>50 (40-74)</td>
</tr>
<tr>
<td>Average number of sinus surgeries (range)</td>
<td>2.4 (0-9)</td>
</tr>
<tr>
<td>Average duration of disease, y</td>
<td>8.2</td>
</tr>
<tr>
<td>Allergic patients, No. (%)</td>
<td>8/12 (67)</td>
</tr>
<tr>
<td>Positive to at least 1 out of 16 common aeroallergens on skin test, No. (%)</td>
<td>6/12 (50)</td>
</tr>
<tr>
<td>Positive to at least 1 out of 23 fungal allergens by RAST, No. (%)</td>
<td>6/12 (50)</td>
</tr>
<tr>
<td>Elevated total IgE, No. (%)</td>
<td>6/12 (50)</td>
</tr>
<tr>
<td>Asthma, No. (%)</td>
<td>10/12 (83)</td>
</tr>
<tr>
<td>Incidence of aspirin intolerance, No. (%)</td>
<td>5/12 (42)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0194599812451010">
<p>Abbreviation: RAST, radioallergosorbent test.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section10-0194599812451010" sec-type="discussion">
<title>Discussion</title>
<p>Gomori methenamine silver stain was originally developed for detection of glycogen and mucin in 1946.<sup><xref ref-type="bibr" rid="bibr20-0194599812451010">20</xref>,<xref ref-type="bibr" rid="bibr21-0194599812451010">21</xref></sup> In 1955, Grocott<sup><xref ref-type="bibr" rid="bibr22-0194599812451010">22</xref></sup> applied Gomori’s stain to identify fungi in tissue sections and smears. Since then, it has become the worldwide standard for histopathological detection of fungi. Grocott also suggested the use of a variety of counterstains to improve the visualization of fungi in the tissue. The GMS stain uses chromic acid to oxidize aldehydes, which are later reduced using the methenamine silver nitrate complex. However, the stain is not specific for the chitin in fungus because glycogen, mucin, and vascular elastase also contain reducible aldehydes, which the stain was originally designed to detect.<sup><xref ref-type="bibr" rid="bibr22-0194599812451010">22</xref></sup> Even the title of Gomori’s original article (“A New Histochemical Test for Glycogen and Mucin”) emphasizes that GMS was originally designed to stain mucin.<sup><xref ref-type="bibr" rid="bibr20-0194599812451010">20</xref></sup> This has profound implications for the detection of fungi in CRS because their potential role is considered a noninvasive one, with fungi located only in the mucus. In essence, the concept of the GMS stain is the attempt to visualize fungal aldehydes in an aldehyde-rich mucus background.</p>
<p>The observation that trypsin digestion enhances the visualization of fungi on a regular GMS stain was a serendipitous one. While applying immunofluorescence stains with immunomarkers to the mucus of CRS patients to study the role of eosinophil degranulation, trypsin digestion was part of the protocol to enhance the antigen-antibody binding site. After counterstaining the immunofluorescence stains with H&amp;E and GMS, we noticed that the fungi were much better visualized on the counterstains than on the regular GMS stains.</p>
<p>The exact mechanism by which trypsin improves the detection of fungi in mucus remains speculative. Digestion of the specimen with trypsin might not only improve the antigen-antibody binding site for the immunofluorescence stains but also enhance the penetration of methenamine silver nitrate into the fungal hyphae cell wall, which contains mannoproteins that include lysine and arginine residues that the trypsin enzyme recognizes and cleaves. In addition, the trypsin might digest the mucus background and improve penetration of the GMS stain into the specimen.<sup><xref ref-type="bibr" rid="bibr23-0194599812451010">23</xref><xref ref-type="bibr" rid="bibr24-0194599812451010"/>-<xref ref-type="bibr" rid="bibr25-0194599812451010">25</xref></sup> Fungi also have been known to display as calcifications on radiographs,<sup><xref ref-type="bibr" rid="bibr26-0194599812451010">26</xref>,<xref ref-type="bibr" rid="bibr27-0194599812451010">27</xref></sup> and calcium deposits are known to reduce silver solutions used in the GMS stain.<sup><xref ref-type="bibr" rid="bibr22-0194599812451010">22</xref></sup> The trypsin may decrease the amount of calcium on the fungal cell wall, improving the efficacy of the methenamine silver stain.<sup><xref ref-type="bibr" rid="bibr13-0194599812451010">13</xref></sup></p>
<p>In this study, complex immunofluorescence stains (chitinase and anti-<italic>Alternaria</italic>) were used to verify that what was aldehyde positive on GMS were indeed fungal hyphae and to ensure the lack of false-positive results, but both stains might also have drawbacks. Although anti-<italic>Alternaria</italic> may cross-react with other fungal species, the chitinase stain seems to depend on the presence of an intact fungal cell wall. On the upside, anti-<italic>Alternaria</italic> appears to stain not only the fungal cell wall but also fungal debris and secretions.</p>
<p>Interestingly, as illustrated in <xref ref-type="fig" rid="fig3-0194599812451010"><bold>Figure 3</bold></xref>, some obvious fungal segments are not labeled by any staining method used in this study. Thus, histologic staining should never be used to exclude the presence of fungi. Given the lack of sensitivity of the GMS stain, one must be careful with the interpretation and conclusion from numerous studies where the GMS method was used to exclude the presence of fungi.<sup><xref ref-type="bibr" rid="bibr6-0194599812451010">6</xref><xref ref-type="bibr" rid="bibr7-0194599812451010"/><xref ref-type="bibr" rid="bibr8-0194599812451010"/><xref ref-type="bibr" rid="bibr9-0194599812451010"/>-<xref ref-type="bibr" rid="bibr10-0194599812451010">10</xref>,<xref ref-type="bibr" rid="bibr16-0194599812451010">16</xref><xref ref-type="bibr" rid="bibr17-0194599812451010"/><xref ref-type="bibr" rid="bibr18-0194599812451010"/>-<xref ref-type="bibr" rid="bibr19-0194599812451010">19</xref>,<xref ref-type="bibr" rid="bibr28-0194599812451010">28</xref></sup> Ferguson<sup><xref ref-type="bibr" rid="bibr10-0194599812451010">10</xref></sup> suggested a new disease entity based on the presence or absence of fungi on GMS staining. She proposed labeling patients who were histologically identical to that of AFS but lacked the presence of fungi on GMS stain as having eosinophilic mucin rhinosinusitis, a notion now challenged by the high false-negative rate of the regular GMS stain demonstrated in this study.</p>
<p>Our study also included a comprehensive allergy workup consisting of total IgE values, as well as prick testing for 16 common aeroallergens and 18 fungal-specific antigens, totaling 398 skin prick tests. In addition, we performed RAST testing for 23 fungal-specific IgE antibodies, totaling 296 RAST tests. In 1994, Bent and Kuhn published an article about the criteria for the diagnosis of AFS.<sup><xref ref-type="bibr" rid="bibr29-0194599812451010">29</xref></sup> Their criteria were based on 15 patients who were preselected “based on the current understanding of the disease,” including the presence of an IgE-mediated allergy. However, this and other studies demonstrate that the histologic features of AFS can be found in the absence of any detectable IgE-mediated allergy<sup><xref ref-type="bibr" rid="bibr2-0194599812451010">2</xref>,<xref ref-type="bibr" rid="bibr11-0194599812451010">11</xref></sup> Thus, the results of this study should fuel the discussion of whether the term <italic>allergic fungal rhinosinusitis</italic> should be changed to the more descriptive <italic>eosinophilic fungal rhinosinusitis</italic> because of the common features of eosinophilic mucin, presence of fungi, and presence of CRS.</p>
<p>Although this study represents only 12 patients, it reflects a comprehensive histologic evaluation of 34 eosinophilic mucin specimens. Each specimen was sectioned and stained with 8 different histological stains, including cumbersome immunohistochemical and individual negative control stains, totaling 272 stains that were evaluated. Collecting a large amount of mucin significantly increased the chances to detect fungi within, and given the resources this kind of evaluation took, we did not want to waste them on specimens without a large quantity of eosinophilic mucin present.</p>
<p>The purpose of this study was to compare different methodologies to detect fungi, rendering each different staining method to be a control for the others. Each immunofluorescence stain also had its respective negative control. Considering the purpose of the study, we did not see any value in having a group of healthy controls, who do not have eosinophils in their mucin and in fact have an inadequate amount of mucin for a valid histologic analysis. Other studies have demonstrated the presence of fungi within mucus from healthy controls.<sup><xref ref-type="bibr" rid="bibr2-0194599812451010">2</xref>,<xref ref-type="bibr" rid="bibr11-0194599812451010">11</xref>,<xref ref-type="bibr" rid="bibr12-0194599812451010">12</xref></sup></p>
<p>Obviously, the identification of fungi in mucin specimens depends on meticulous collection, preservation, and processing techniques.<sup><xref ref-type="bibr" rid="bibr11-0194599812451010">11</xref></sup> It must be emphasized that the patients in this study were preselected for having a large amount of mucus present, enhancing the chance for detecting fungi. Thus, the results of the study should not be used to make conclusions regarding the role of those fungi in CRS, nor should they be considered representative for CRS in general. This study was meant to enable the practicing rhinologic and sinus surgeon to enhance the detection of fungi on histopathology and to exercise caution in the interpretation of negative GMS staining results to exclude the presence of fungi. Otolaryngologists often have suspected a fungal presence in the mucus of their CRS patients, but pathology has failed to support the suspicion. We hope that the trypsin-digested GMS stain will help to reduce the number of false-negative results.</p>
</sec>
<sec id="section11-0194599812451010" sec-type="conclusions">
<title>Conclusion</title>
<p>The inability to detect fungus in the mucus of CRS patients is due to the limitations of the GMS stain. This study presents an enhanced and cost-effective method to increase the detection of fungi without the use of immunofluorescence staining such as chitinase and anti-<italic>Alternaria</italic>. Eosinophilic mucin and fungi on histopathology are present in both allergic and nonallergic patients. Thus, the term <italic>allergic mucin</italic> should be replaced by the more descriptive term <italic>eosinophilic mucin</italic>.</p>
</sec>
<sec id="section12-0194599812451010">
<title>Author Contributions</title>
<p><bold>Canting Guo</bold>, acquisition, analysis and interpretation of data, drafting and final approval of manuscript; <bold>Saied Ghadersohi</bold>, acquisition, analysis and interpretation of data, drafting and final approval of manuscript; <bold>Gail M. Kephart</bold>, acquisition, analysis and interpretation of data, drafting and final approval of manuscript; <bold>Roger A. Laine</bold>, final approval of manuscript; <bold>David A. Sherris</bold>, final approval of manuscript; <bold>Hirohita Kita</bold>, final approval of manuscript; <bold>Jens U. Ponikau</bold>, acquisition of data, analysis and interpretation, drafting and final approval of manuscript.</p>
</sec>
<sec id="section13-0194599812451010">
<title>Disclosures</title>
<p><bold>Competing interests:</bold> Roger A. Laine, President of Anomeric, Inc; Managing Partner of TumorEnd, LLC.</p>
<p><bold>Sponsorships:</bold> None.</p>
<p><bold>Funding source:</bold> Supported by a grant from the National Institutes of Health (AI49235) and by the Gromo Foundation for Medical Research and Education (Buffalo, New York). The funding source supported the authors’ contribution to data collection, analysis and interpretation of data, writing, and approval of the manuscript.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="presented-at">
<p>Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0194599812451010">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pleis</surname><given-names>J</given-names></name>
<name><surname>Lethbridge-Cejku</surname><given-names>M</given-names></name>
</person-group>. <article-title>Summary health statistics for US adults: National Health Interview Survey, 2006</article-title>. <source>Vital Health Stat</source>. <year>2007</year>;<volume>10</volume>:<fpage>1</fpage>-<lpage>153</lpage>.</citation>
</ref>
<ref id="bibr2-0194599812451010">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Braun</surname><given-names>H</given-names></name>
<name><surname>Buzina</surname><given-names>W</given-names></name>
<name><surname>Freudenschuss</surname><given-names>K</given-names></name>
<name><surname>Beham</surname><given-names>A</given-names></name>
<name><surname>Stammberger</surname><given-names>H</given-names></name>
</person-group>. <article-title>Eosinophilic fungal rhinosinusitis: a common disorder in Europe?</article-title> <source>Laryngoscope</source>. <year>2003</year>;<volume>113</volume>:<fpage>264</fpage>-<lpage>269</lpage>.</citation>
</ref>
<ref id="bibr3-0194599812451010">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harlin</surname><given-names>SL</given-names></name>
<name><surname>Ansel</surname><given-names>DG</given-names></name>
<name><surname>Lane</surname><given-names>SR</given-names></name>
<name><surname>Myers</surname><given-names>J</given-names></name>
<name><surname>Kephart</surname><given-names>GM</given-names></name>
<name><surname>Gleich</surname><given-names>GJ</given-names></name>
</person-group>. <article-title>A clinical and pathologic study of chronic sinusitis: the role of the eosinophil</article-title>. <source>J Allergy Clin Immunol</source>. <year>1988</year>;<volume>81</volume>:<fpage>867</fpage>-<lpage>875</lpage>.</citation>
</ref>
<ref id="bibr4-0194599812451010">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bhattacharyya</surname><given-names>N</given-names></name>
<name><surname>Vyas</surname><given-names>D</given-names></name>
<name><surname>Fechner</surname><given-names>F</given-names></name>
<name><surname>Gliklich</surname><given-names>R</given-names></name>
<name><surname>Metson</surname><given-names>R</given-names></name>
</person-group>. <article-title>Tissue eosinophilia in chronic sinusitis</article-title>. <source>Arch Otolaryngol Head Neck Surg</source>. <year>2001</year>;<volume>127</volume>:<fpage>1102</fpage>-<lpage>1105</lpage>.</citation>
</ref>
<ref id="bibr5-0194599812451010">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Millar</surname><given-names>JW</given-names></name>
<name><surname>Johnston</surname><given-names>A</given-names></name>
<name><surname>Lamb</surname><given-names>D</given-names></name>
</person-group>. <article-title>Allergic aspergillosis of the maxillary sinuses</article-title>. <source>Thorax</source>. <year>1981</year>;<volume>36</volume>:<fpage>710</fpage>.</citation>
</ref>
<ref id="bibr6-0194599812451010">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Katzenstein</surname><given-names>A</given-names></name>
<name><surname>Sale</surname><given-names>S</given-names></name>
<name><surname>Greenberger</surname><given-names>P</given-names></name>
</person-group>. <article-title>Allergic <italic>Aspergillus</italic> sinusitis: a newly recognised form of sinusitis</article-title>. <source>J Allergy Clin Immunol</source>. <year>1983</year>;<volume>72</volume>:<fpage>89</fpage>-<lpage>93</lpage>.</citation>
</ref>
<ref id="bibr7-0194599812451010">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Robson</surname><given-names>JM</given-names></name>
<name><surname>Hogan</surname><given-names>PG</given-names></name>
<name><surname>Benn</surname><given-names>RA</given-names></name>
<name><surname>Gatenby</surname><given-names>PA</given-names></name>
</person-group>. <article-title>Allergic fungal sinusitis presenting as paranasal sinus tumour</article-title>. <source>Aust N Z J Med</source>. <year>1989</year>;<volume>19</volume>:<fpage>351</fpage>-<lpage>353</lpage>.</citation>
</ref>
<ref id="bibr8-0194599812451010">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Allphin</surname><given-names>AL</given-names></name>
<name><surname>Strauss</surname><given-names>M</given-names></name>
<name><surname>Abdul-Karim</surname><given-names>FW</given-names></name>
</person-group>. <article-title>Allergic fungal sinusitis: problems in diagnosis and treatment</article-title>. <source>Laryngoscope</source>. <year>1991</year>;<volume>101</volume>:<fpage>815</fpage>-<lpage>820</lpage>.</citation>
</ref>
<ref id="bibr9-0194599812451010">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cody</surname><given-names>D</given-names></name>
<name><surname>Neel</surname><given-names>H</given-names></name>
<name><surname>Ferreiro</surname><given-names>J</given-names></name>
<name><surname>Roberts</surname><given-names>G</given-names></name>
</person-group>. <article-title>Allergic fungal sinusitis: the Mayo Clinic experience</article-title>. <source>Laryngoscope</source>. <year>1994</year>;<volume>104</volume>:<fpage>1074</fpage>-<lpage>1079</lpage>.</citation>
</ref>
<ref id="bibr10-0194599812451010">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ferguson</surname><given-names>B</given-names></name>
</person-group>. <article-title>Eosinophilic mucin rhinosinusitis: a distinct clinicopathological entity</article-title>. <source>Laryngoscope</source>. <year>2000</year>;<volume>110</volume>:<fpage>799</fpage>-<lpage>813</lpage>.</citation>
</ref>
<ref id="bibr11-0194599812451010">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ponikau</surname><given-names>J</given-names></name>
<name><surname>Sherris</surname><given-names>D</given-names></name>
<name><surname>Kern</surname><given-names>EB</given-names></name>
<etal/>
</person-group>. <article-title>The diagnosis and incidence of allergic fungal sinusitis</article-title>. <source>Mayo Clin Proc</source>. <year>1999</year>;<volume>74</volume>:<fpage>877</fpage>-<lpage>884</lpage>.</citation>
</ref>
<ref id="bibr12-0194599812451010">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gosepath</surname><given-names>J</given-names></name>
<name><surname>Brieger</surname><given-names>J</given-names></name>
<name><surname>Vlachtsis</surname><given-names>K</given-names></name>
<name><surname>Mann</surname><given-names>W</given-names></name>
</person-group>. <article-title>Fungal DNA is present in tissue specimens of patients with chronic rhinosinusitis</article-title>. <source>Am J Rhinol</source>. <year>2004</year>;<volume>18</volume>:<fpage>9</fpage>-<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr13-0194599812451010">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shin</surname><given-names>SH</given-names></name>
<name><surname>Ponikau</surname><given-names>J</given-names></name>
<name><surname>Sherris</surname><given-names>DA</given-names></name>
<etal/>
</person-group>. <article-title>Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi</article-title>. <source>J Allergy Clin Immunol</source>. <year>2004</year>;<volume>114</volume>:<fpage>1369</fpage>-<lpage>1375</lpage>.</citation>
</ref>
<ref id="bibr14-0194599812451010">
<label>14.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Laine</surname><given-names>RA</given-names></name>
<name><surname>Lo</surname><given-names>JC</given-names></name>
<name><surname>Zhu</surname><given-names>BR</given-names></name>
</person-group>. <article-title>Catalytically inactive endoglycosidases as microbial diagnostic reagents: chitinases and lysozymes as fungal and bacterial capture/label agents</article-title>. In: <person-group person-group-type="editor">
<name><surname>Nilsson</surname><given-names>CL</given-names></name>
</person-group>, ed. <source>Lectins—Analytical Technologies</source>. <publisher-loc>Amsterdam, the Netherlands</publisher-loc>: <publisher-name>Elsevier BV</publisher-name>; <year>2007</year>:<fpage>373</fpage>-<lpage>384</lpage>.</citation>
</ref>
<ref id="bibr15-0194599812451010">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Taylor</surname><given-names>M</given-names></name>
<name><surname>Ponikau</surname><given-names>J</given-names></name>
<name><surname>Sherris</surname><given-names>D</given-names></name>
<etal/>
</person-group>. <article-title>Detection of fungal organisms in eosinophilic mucin using a fluorescein-labeled chitin-specific binding protein</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>2002</year>;<volume>127</volume>:<fpage>377</fpage>-<lpage>383</lpage>.</citation>
</ref>
<ref id="bibr16-0194599812451010">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Das</surname><given-names>A</given-names></name>
<name><surname>Bal</surname><given-names>A</given-names></name>
<name><surname>Charkrabarti</surname></name>
<name><surname>Panda</surname><given-names>N</given-names></name>
<name><surname>Joshi</surname><given-names>K</given-names></name>
</person-group>. <article-title>Spectrum of fungal rhinosinusitis: histopathologist’s perspective</article-title>. <source>Histopathology</source>. <year>2009</year>;<volume>54</volume>:<fpage>854</fpage>-<lpage>859</lpage>.</citation>
</ref>
<ref id="bibr17-0194599812451010">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Collins</surname><given-names>M</given-names></name>
<name><surname>Nair</surname><given-names>S</given-names></name>
<name><surname>Wormald</surname><given-names>P</given-names></name>
</person-group>. <article-title>Prevalence of noninvasive fungal sinusitis in South Australia</article-title>. <source>Am J Rhinol</source>. <year>2003</year>;<volume>17</volume>:<fpage>127</fpage>-<lpage>132</lpage>.</citation>
</ref>
<ref id="bibr18-0194599812451010">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Granville</surname><given-names>L</given-names></name>
<name><surname>Chirala</surname><given-names>M</given-names></name>
<name><surname>Cernoch</surname><given-names>P</given-names></name>
<name><surname>Ostrowski</surname><given-names>M</given-names></name>
<name><surname>Truong</surname><given-names>L</given-names></name>
</person-group>. <article-title>Fungal sinusitis: histologic spectrum and correlation with culture</article-title>. <source>Hum Pathol</source>. <year>2003</year>;<volume>35</volume>:<fpage>474</fpage>-<lpage>481</lpage>.</citation>
</ref>
<ref id="bibr19-0194599812451010">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Saravanan</surname><given-names>K</given-names></name>
<name><surname>Panda</surname><given-names>N</given-names></name>
<name><surname>Chakrabarti</surname><given-names>A</given-names></name>
<name><surname>Das</surname><given-names>A</given-names></name>
<name><surname>Bapuraj</surname><given-names>R</given-names></name>
</person-group>. <article-title>Allergic fungal rhinosinusitis: an attempt to resolve the diagnostic dilemma</article-title>. <source>Arch Otolaryngol Head Neck Surg</source>. <year>2006</year>;<volume>132</volume>:<fpage>173</fpage>-<lpage>178</lpage>.</citation>
</ref>
<ref id="bibr20-0194599812451010">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gomori</surname><given-names>G</given-names></name>
</person-group>. <article-title>A new histochemical test for glycogen and mucin</article-title>. <source>Am J Clin Pathol</source>. <year>1946</year>;<volume>10</volume>:<fpage>177</fpage>-<lpage>179</lpage>.</citation>
</ref>
<ref id="bibr21-0194599812451010">
<label>21.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Gomori</surname><given-names>G</given-names></name>
</person-group>. <source>Microscopic Histochemistry: Principles and Practice</source>. <publisher-loc>Chicago</publisher-loc>: <publisher-name>University of Chicago Press</publisher-name>; <year>1952</year>:<fpage>68</fpage>.</citation>
</ref>
<ref id="bibr22-0194599812451010">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grocott</surname><given-names>RG</given-names></name>
</person-group>. <article-title>A stain for fungi in tissue sections and smears using Gomori’s methamine-silver nitrate technic</article-title>. <source>Am J Clin Pathol</source>. <year>1955</year>;<volume>25</volume>:<fpage>975</fpage>-<lpage>979</lpage>.</citation>
</ref>
<ref id="bibr23-0194599812451010">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Boisrame</surname><given-names>A</given-names></name>
<name><surname>Gaillardin</surname><given-names>C</given-names></name>
</person-group>. <article-title>Heterologous expression and characterization of a B-1,6-glucanase from</article-title> <source>Aspergillus fumigatus. Appl Microbiol Biotechnol</source>. <year>2009</year>;<volume>82</volume>:<fpage>663</fpage>-<lpage>669</lpage>.</citation>
</ref>
<ref id="bibr24-0194599812451010">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Levitz</surname><given-names>S</given-names></name>
<name><surname>Sprecht</surname><given-names>C</given-names></name>
</person-group>. <article-title>The molecular basis for the immunogenicity of <italic>Cryptococcus neoformans</italic> mannoproteins</article-title>. <source>FEMS Yeast Res</source>. <year>2006</year>;<volume>6</volume>:<fpage>513</fpage>-<lpage>524</lpage>.</citation>
</ref>
<ref id="bibr25-0194599812451010">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Valle</surname><given-names>R</given-names></name>
<name><surname>Sandini</surname><given-names>S</given-names></name>
<name><surname>Gomex</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Generation of a recombinant 65-kilodalton mannoprotein, a major antigen target of cell-mediated immune response to <italic>Candida albicans</italic></article-title>. <source>Infect Immun</source>. <year>2000</year>;<volume>68</volume>:<fpage>6777</fpage>-<lpage>6784</lpage>.</citation>
</ref>
<ref id="bibr26-0194599812451010">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Corey</surname><given-names>JP</given-names></name>
</person-group>. <article-title>Allergic fungal sinusitis</article-title>. <source>Otolaryngol Clin North Am</source>. <year>1992</year>;<volume>25</volume>:<fpage>225</fpage>-<lpage>230</lpage>.</citation>
</ref>
<ref id="bibr27-0194599812451010">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zinreich</surname><given-names>J</given-names></name>
</person-group>. <article-title>Imaging of inflammatory sinus disease</article-title>. <source>Otolaryngol Clin North Am</source>. <year>1993</year>;<volume>26</volume>:<fpage>535</fpage>-<lpage>547</lpage>.</citation>
</ref>
<ref id="bibr28-0194599812451010">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hutcheson</surname><given-names>PS</given-names></name>
<name><surname>Schubert</surname><given-names>MS</given-names></name>
<name><surname>Slavin</surname><given-names>RG</given-names></name>
</person-group>. <article-title>Distinctions between allergic fungal rhinosinusitis and chronic rhinosinusitis</article-title>. <source>Am J Rhinol Allergy</source>. <year>2010</year>;<volume>24</volume>:<fpage>405</fpage>-<lpage>408</lpage>.</citation>
</ref>
<ref id="bibr29-0194599812451010">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bent</surname><given-names>J</given-names></name>
<name><surname>Kuhn</surname><given-names>F</given-names></name>
</person-group>. <article-title>Diagnosis of allergic fungal sinusitis</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>1994</year>;<volume>111</volume>:<fpage>580</fpage>-<lpage>588</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>